PT Kalbe Farma Tbk's Total Assets for the quarter that ended in Mar. 2024 was $1,879 Mil.
Warning Sign:
If a company builds assets at 10.1% a year, faster than its revenue growth rate of 8.3% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, PT Kalbe Farma Tbk's average Total Assets Growth Rate was 0.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 11.30% per year.
During the past 5 years, the average Total Assets Growth Rate was 10.10% per year.
During the past 10 years, the average Total Assets Growth Rate was 9.80% per year.
During the past 13 years, PT Kalbe Farma Tbk's highest 3-Year average Total Assets Growth Rate was 23.70%. The lowest was 7.80%. And the median was 11.30%.
The historical data trend for PT Kalbe Farma Tbk's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
PT Kalbe Farma Tbk's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kalbe Farma Tbk (OTCPK:PTKFY) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
PT Kalbe Farma Tbk's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
PT Kalbe Farma Tbk Total Assets Related Terms
Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PTKFY has been successfully added to your 